| Literature DB >> 30785923 |
Blanca Gavilán-Carrera1, Jaqueline Garcia da Silva2, José A Vargas-Hitos3, José M Sabio3, Pablo Morillas-de-Laguno1, Raquel Rios-Fernández4, Manuel Delgado-Fernández1, Alberto Soriano-Maldonado5,6.
Abstract
OBJECTIVES: To study the association of different components of physical fitness [flexibility, muscle strength and cardiorespiratory fitness (CRF)] and a clustered fitness score with health-related quality of life (HRQoL) in women with systemic lupus erythematosus (SLE) and to analyze whether participants with high fitness level have better HRQoL.Entities:
Mesh:
Year: 2019 PMID: 30785923 PMCID: PMC6382148 DOI: 10.1371/journal.pone.0212436
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of inclusion of women with systemic lupus erythematosus (SLE) for the present study.
SF-36: 36-item Short-Form Health Survey.
Sociodemographic and clinical characteristics (n = 70).
| mean | SD | |
|---|---|---|
| Age (years) | 42.5 | 13.9 |
| Weight (kg) | 65.4 | 11.2 |
| Body mass index (kg/m2) | 25.5 | 4.6 |
| Disease duration (years) | 13.5 | 10.0 |
| SLEDAI (0–105) | 0.7 | 1.6 |
| Systemic Damage Index for SLE (0–46) | 0.5 | 1.0 |
| Current corticoicorteroids intake (yes, %) | 45 | 64.3 |
| Daily corticorteroids dose (mg/day) | 3.8 | 4.9 |
| Cumulative corticorteroids exposure (last 3 years) mg | 2827.3 | 2704.1 |
| Hydroxychloroquine intake (yes, %) | 62 | 88.6 |
| Daily hydroxychloroquine dose (mg/day) | 196.5 | 117.2 |
| Immunosuppressants (current intake) (yes, %) | 33 | 47.9 |
| Immunosuppressants (previous intake) (yes, %) | 30 | 42.9 |
| Organ involvement (yes, %) | ||
| Joint involvement | 50 | 71.4 |
| Neurological involvement | 6 | 8.6 |
| Lung involvement | 1 | 1.4 |
| BDI-II total score (0–63) | 11.8 | 9.0 |
| MFI general fatigue (0–20) | 13.4 | 4.2 |
| Physical fitness tests | ||
| | ||
| Back scratch dominant (cm) | 2.0 | 9.3 |
| Back scratch no dominant (cm) | -2.5 | 10.9 |
| Back scratch mean (cm) | -0.3 | 9.6 |
| Hand-grip strength dominant (cm) | 24.1 | 5.5 |
| Hand-grip strength no dominant (cm) | 23.7 | 5.2 |
| Hand-grip strength mean (cm) | 23.9 | 5.2 |
| 30-sec chair stand test (repetitions) | 15.0 | 3.2 |
| 6-min walk test (m) | 570.8 | 71.8 |
| Lower body strength (yes, %) | 43 | 60.6 |
| Cardiorespiratory fitness (yes, %) | 25 | 50.7 |
| Health-related quality of life (SF-36) (0–100) | ||
| Physical functioning | 75.9 | 21.0 |
| Physical role | 66.5 | 24.7 |
| Bodily pain | 55.4 | 24.2 |
| General health | 42.2 | 19.8 |
| Vitality | 52.0 | 22.7 |
| Social functioning | 75.2 | 23.5 |
| Role emotional | 81.4 | 24.5 |
| Mental health | 65.3 | 18.6 |
| SF-36 physical component summary | 42.6 | 9.0 |
| SF-36 mental component summary | 46.7 | 10.6 |
BDI-II: Beck Depression Inventory second edition; BMI: Body Mass Index; MFI: Multidimensional Fatigue Inventory; SF-36: 36-item Short-Form Health Survey; SD: standard deviation; SLEDAI: systemic lupus erythematosus disease activity index
† Criterion-referenced fitness standards proposed by Rikli and Jones (2013) for women aged 60–64: lower body strength assessed by the 30-sec chair stand test = 15 repetitions; cardiorespiratory fitness assessed by the 6-min walk test = 571.5 meters.
Sociodemographic and clinical characteristic of the participants according to fitness level.
| Fexibility | Strength | CRF | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Back Scratch Test | Handgrip | 30-sec chair stand | 6-min walk test | |||||||||
| Low | High | Low | High | Low | High | Low | High | |||||
| ( | ( | ( | ( | ( | ( | ( | ( | |||||
| mean | mean | mean | mean | mean | mean | mean | mean | |||||
| Age (years) | 46.0 (14.2) | 39.0 (12.9) | 0.037 | 44.1 (15.8) | 40.9 (11.7) | 0.353 | 50.1 (13.1) | 34.9 (10.1) | <0.001 | 46.8 (14.3) | 34.7 (9.9) | 0.002 |
| Weight (kg) | 67.3 (14.0) | 63.6 (7.1) | 0.173 | 64.1 (9.7) | 66.8 (12.5) | 0.311 | 67.4 (11.5) | 63.5 (10.7) | 0.153 | 69.6 (15.4) | 62.4 (6.7) | 0.049 |
| Body mass index (kg/m2) | 26.9 (5.5) | 24.1 (3.1) | 0.01 | 25.7 (4.2) | 25.4 (5.1) | 0.775 | 26.4 (4.6) | 24.6 (4.5) | 0.105 | 28.4 (5.8) | 23.2 (1.6) | <0.001 |
| Disease duration (years) | 15.0 (10.1) | 11.9 (9.9) | 0.192 | 15.9 (10.7) | 11.0 (8.7) | 0.042 | 16.5 (11.0) | 10.4 (8.0) | 0.009 | 14.7 (10.0) | 8.0 (6.8) | 0.01 |
| SLEDAI (0–105) | 0.69 (1.5) | 0.8 (1.6) | 0.763 | 0.7 (1.5) | 0.7 (1.6) | 1.000 | 1.0 (1.8) | 0.5 (1.2) | 0.128 | 1.1 (1.9) | 1.0 (1.6) | 0.831 |
| Systemic Damage Index for SLE | 0.49 (1.0) | 0.5 (1.0) | 0.902 | 0.7 (1.2) | 0.2 (0.6) | 0.017 | 0.8 (1.2) | 0.2 (0.4) | 0.008 | 0.7 (1.1) | 0.2 (0.4) | 0.057 |
| Current corticoicorteroids intake | 22 (62.9) | 23 (65.7) | 1.000 | 24 (68.6) | 21 (60.0) | 0.618 | 22 (62.9) | 23 (65.7) | 1.000 | 17 (63.0) | 16 (72.7) | 0.549 |
| Daily corticorteroids dose (mg/day) | 4.1 (5.6) | 3.6 (4.1) | 0.649 | 4.6 (6.0) | 3.0 (3.3) | 0.169 | 3.9 (5.6) | 3.8 (4.1) | 0.976 | 4.4 (6.1) | 3.8 (3.1) | 0.682 |
| Cumulative corticorteroids exposure | 2368.2 (2477.4) | 3299.9 (2879.3) | 0.154 | 3407.6 (2956.3) | 2230.0 (2310.5) | 0.07 | 2490.0 (2651.7) | 3174.5 (2752.8) | 0.297 | 2445.1 (2593.7) | 3185.4 (2784.6) | 0.341 |
| Hydroxychloroquine intake | 31 (88.6) | 31 (88.6) | 1.000 | 30 (85.7) | 32 (91.4) | 0.71 | 30 (85.7) | 32 (91.4) | 0.71 | 24 (88.9) | 21 (95.5) | 0.617 |
| (yes, %) | ||||||||||||
| Daily hydroxychloroquine dose (mg/day) | 197.2 (122.0) | 195.9 (113.9) | 0.965 | 185.3 (113.3) | 207.8 (121.5) | 0.427 | 186.1 (120.1) | 206.9 (114.9) | 0.462 | 188.9 (111.1) | 241.5 (119.5) | 0.117 |
| Immunosuppressants | 15 (42.9) | 18 (51.4) | 0.632 | 19 (54.3) | 14 (40.0) | 0.338 | 13 (37.1) | 20 (57.1) | 0.15 | 10 (37.0) | 11 (50.0) | 0.398 |
| (current intake) (yes, %) | ||||||||||||
| Immunosuppressants | 14 (40.0) | 16 (45.7) | 0.809 | 18 (51.4) | 12 (34.3) | 0.227 | 11 (31.4) | 19 (54.3) | 0.09 | 9 (33.3) | 11 (50.0) | 0.26 |
| (previous intake) (yes, %) | ||||||||||||
| Organ involvement (yes, %) | ||||||||||||
| Joint involvement | 26 (74.3) | 24 (68.6) | 0.792 | 25 (71.4) | 25 (71.4) | 1.000 | 28 (80.0) | 22 (62.9) | 0.185 | 17 (63.0) | 14 (63.6) | 1.000 |
| Neurological involvement | 2 (5.7) | 4 (11.4) | 0.428 | 3 (8.6) | 3 (8.6) | 1.000 | 5 (14.3) | 1 (2.9) | 0.198 | 2 (7.4) | 2 (9.1) | 1.000 |
| BDI-II total score (0–63) | 10.60 (8.0) | 12.9 (9.8) | 0.284 | 11.0 (9.2) | 12.5 (8.8) | 0.484 | 11.4 (8.2) | 12.1 (9.7) | 0.742 | 13.9 (8.9) | 12.1 (9.8) | 0.515 |
| MFI general fatigue (0–20) | 13.57 (4.9) | 13.3 (3.4) | 0.757 | 13.3 (4.7) | 13.5 (3.7) | 0.888 | 13.7 (4.4) | 13.1 (4.1) | 0.518 | 14.3 (4.3) | 13.3 (4.3) | 0.453 |
Values are mean (SD) unless otherwise is indicated
An independent t test and χ2 test were used to compare variables between groups
Low and high fitness level according to the median value for flexibility (1.35 cm in the back scratch test), upper body strength (28.28 kg/cm2 in the handgrip test), lower body strength (15 repetitions in the 30-sec chair stand test) and cardiorespiratory fitness (CRF; 575 m in the 6-min walk test).
Partial correlations assessing the association of physical fitness components with HRQoL (n = 70).
| Back scratch dominant (cm) | Back scratch non-dominant (cm) | Back scratch mean (cm) | Handgrip dominant (Kg) | Handgrip non-dominant (Kg) | Handgrip mean (Kg) | 30-sec chair stand (repetitions) | 6-MWT (meters) | |
|---|---|---|---|---|---|---|---|---|
| Physical function | 0.192 | 0.314 | 0.279 | 0.472 | 0.478 | 0.490 | 0.491 | 0.648 |
| Physical role | 0.088 | 0.191 | 0.156 | 0.222 | 0.306 | 0.268 | 0.315 | 0.267 |
| Bodily pain | 0.092 | 0.127 | 0.119 | 0.343 | 0.259 | 0.314 | 0.396 | 0.390 |
| General health | 0.159 | 0.185 | 0.186 | 0.074 | 0.148 | 0.108 | 0.022 | 0.014 |
| Vitality | -0.142 | -0.067 | -0.107 | 0.067 | 0.135 | 0.1 | 0.204 | -0.111 |
| Social functioning | -0.215 | -0.262 | -0.259 | 0.099 | 0.17 | 0.129 | 0.111 | 0.164 |
| Emotional role | 0.02 | 0.089 | 0.063 | 0.047 | 0.062 | 0.055 | 0.162 | 0.108 |
| Mental health | -0.068 | -0.073 | -0.076 | -0.098 | -0.212 | -0.15 | 0.13 | 0.085 |
| Physical component | 0.191 | 0.286 | 0.262 | 0.424 | 0.470 | 0.456 | 0.408 | 0.478 |
| Mental component | -0.218 | -0.227 | -0.239 | -0.188 | -0.204 | -0.201 | 0.021 | -0.153 |
CRF: Cardiorespiratory fitness. HRQoL: Health-related quality of life. SF-36: 36-item Short-Form Health Survey. 6-MWT: 6-min walk test. Age, body mass index, depression and general fatigue were entered were entered as covariates.
a n = 69
b n = 49
* p<0.05
** p<0.01
*** p<0.001.
Coefficients of linear regression models assessing the association of the clustered fitness scores with HRQoL (n = 49).
| (95% CI) | |||||
|---|---|---|---|---|---|
| Physical role | 0.297 | 8.673 | -0.910 | 18.255 | 0.075 |
| General health | 0.036 | 0.821 | -6.394 | 8.036 | 0.820 |
| Vitality | -0.081 | -2.313 | -9.562 | 4.936 | 0.523 |
| Social functioning | 0.032 | 0.991 | -7.415 | 9.397 | 0.813 |
| Emotional role | 0.104 | 2.993 | -4.546 | 10.533 | 0.428 |
| Mental health | -0.016 | -0.358 | -5.831 | 5.114 | 0.896 |
| Mental component | -0.171 | -2.324 | -5.300 | 0.652 | 0.123 |
HRQoL: Health-related quality of life. SF-36: 36-item Short-Form Health Survey B, unstandardized coefficient; β, standardized coefficient.
Models were created using the “enter” method including age, body mass index, depression, and general fatigue as covariates. Significant associations are highlighted in bold.
Fig 2Means (95% confidence interval) of scores in the 36-item Short-Form Health Survey (SF-36) in patients with low and high fitness level according to the median value for flexibility (1.35 cm in the back scratch test), cardiorespiratory fitness (CRF; 575 m in the 6-min walk test), upper body strength (28.28 kg/cm2 in the handgrip test) and lower body strength (15 repetitions in the 30-sec chair stand test).
Differences between groups were studied using analysis of covariance (ANCOVA) with age, body mass index, depression scores and general fatigue entered as covariates. *p≤0.05 **p≤0.01 *** p≤0.001.